Venetoclax

• Post Date:

  Apr 02,2025

• Expiry Date:

  Apr 02,2026

• Detailed Description:

  Cas No. :1257044-40-8 ABT-199, HR-positive, Her2-negative andvance ormetastaticbreast cancers

• CAS Registry Number:

  1257044-40-8

• Synonyms:

  ;Venetoclax;GDC-0199;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-benzamide;Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(3-nitro-4-((tetrahydro-2H-pyran-4-yl)methylamino)phenylsulfonyl)benzamide;

• Molecular Formula:

  C₄₅H₅₀ClN₇O₇S

• Molecular Weight:

  868.43900

• Molecular Structure:

  

• Company:

  Changzhou Pharmaceutical Factory     [ China ]          

• Contact:

  Manager Shen;Joyce Zhang;Morena Xu

• Tel:

  +86-519-68010600; 88821493; 88

• Fax:

  +86-519-88828412;88256855

• Email:

  zhangyajuan@czpharma.com